Cases / Experience

Throughout our history, we have developed projects in diverse decision-making contexts, across various therapeutic areas, and across Latin America. Our expertise is based on the rigorous application of economic evaluation methods, health technology assessment, and health outcomes analysis to real-world decision-making problems.

Types of projects developed

Health Technology Assessment (HTA)

Assessments for coverage and inclusion decisions
Preparation of technical and economic dossiers
Comparative evaluations of therapeutic alternatives

Health Economics and Modeling

Cost-effectiveness and cost-utility models
Budget impact analysis
Decision and survival models

HEOR & Real World Evidence

Observational studies with real-world data
Service utilization and cost analysis
Patient-centered outcome measurement

Market Access and Value Strategy

Building value stories
Developing value propositions for decision-makers
Providing analytical support for access and coverage processes

Training and Education

Training programs for technical teams
Applied workshops in HTA and health economics

Examples of selected projects

Technology assessment for coverage decision

Vaccines | Central America & the Caribbean

Problem addressed: the need to support decisions regarding the inclusion of various vaccines in immunization programs, considering their clinical and economic impacts.
Approach applied: economic evaluations with disease burden analysis, effectiveness scenarios, and adaptation to local contexts.
Type of decision supported: coverage and prioritization in public health.

Economic models of cost-effectiveness and budget impact

Vaccines for respiratory infections | South America

Problem addressed: Estimating the economic value of a prevention strategy in specific populations, within a context of budget constraints.
Approach applied: Economic modeling with differentiation by risk groups, scenario analysis, and attenuation of effectiveness over time.
Type of decision supported: Budget planning and efficiency evaluation.

Cost-utility model in oncology

Cancer | Latin America

Problem addressed: comparing cancer treatment alternatives considering clinical benefits, adverse events, and economic consequences.
Approach applied: cost-utility analysis with survival modeling, incorporation of disutilities and costs associated with adverse events.
Type of decision supported: therapeutic prioritization and informed decision-making.

Budget impact analysis for high-cost technologies

Rare diseases | Latin America

Problem addressed: evaluating the financial sustainability of incorporating innovative therapies into healthcare systems with limited resources.
Approach applied: modeling the budget impact using phased adoption scenarios and sensitivity analysis.
Type of decision supported: financial planning and negotiation.

Economic burden of disease study

Respiratory diseases | Latin America

Problem addressed: quantifying the direct and indirect economic impact of a disease on different age groups.
Applied approach: analysis of resource utilization, direct medical costs, and cost estimation throughout the course of the disease.
Type of decision supported: prioritization of preventive interventions and resource allocation.

Analytical support for access and value strategies

Cardiometabolic and chronic diseases | Latin America

Problem addressed: the need to translate clinical and economic evidence into value arguments that are understandable to decision-makers.
Approach applied: integration of HTA results, economic modeling, and real-world evidence into value stories adapted to the local context.
Type of decision supported: access, coverage, and positioning processes.

Applied training programs in health economics and HTA

Technical teams | Latin America

Problem addressed: strengthening internal technical capacities for technology assessment and evidence-based decision-making.
Approach: case-based training, applied discussion, and practical exercises.
Type of decision supported: improvement of internal processes and analytical quality.

Regional and therapeutic scope

Our experience includes projects developed in Mexico, Central America, the Caribbean, and South America, across therapeutic areas including vaccines, oncology, and chronic, infectious, and rare diseases.

How we work

Each project is developed based on the decision problem, the local context, and the available evidence. Our approach combines methodological rigor, an understanding of the healthcare system, and clear communication of results to support decision-making.